Axiom Investors’s eHealth EHTH Stock Holding History

Axiom Investors’s Portfolio EHTH Stock Details EHTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-134,955	Closed	-$13M	–	115
2019 Q4	$13M	Sell	134,955 -190,977	-59%	-$14.8M	0.3%	54
2019 Q3	$21.8M	Buy	325,932 +116,459	+56%	+$10.5M	0.59%	50
2019 Q2	$18M	Buy	+209,473	New	+$14.1M	0.49%	44
2018 Q1	–	Sell	-62,355	Closed	-$1.08M	–	153
2017 Q4	$1.08M	Buy	+62,355	New	+$1.39M	0.03%	135

Other funds holding EHTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Axiom Investors's EHTH Position: Q1 2020 in Review

Axiom Investors sold out of eHealth (EHTH) in Q1 2020, closing a stake of 134,955 shares — an estimated $13M sold.

Axiom Investors first reported a position in EHTH in Q4 2017 and held it in 4 quarters. The position peaked at $21.8M in Q3 2019. 276 funds tracked by Wall St. Rank hold EHTH as of Q1 2020.

Axiom Investors reported no remaining eHealth position as of Q1 2020 after selling out during the quarter.
Axiom Investors sold 134,955 eHealth shares in Q1 2020, an estimated $13M.
Axiom Investors first reported a position in eHealth in Q4 2017 and held it in 4 quarters.
Axiom Investors's eHealth position peaked at $21.8M in Q3 2019.
276 funds tracked by Wall St. Rank held eHealth as of Q1 2020.

Based on Axiom Investors's 13F filing for Q1 2020, filed 14 May 2020.